Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/116950
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHeise, Niels Valentin-
dc.contributor.authorQuast, Jeremy-
dc.contributor.authorCsuk, René-
dc.date.accessioned2024-10-21T06:45:39Z-
dc.date.available2024-10-21T06:45:39Z-
dc.date.issued2024-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/118910-
dc.identifier.urihttp://dx.doi.org/10.25673/116950-
dc.description.abstractThe scientific community has long been interested in capsaicin, and the extensive hunt for AChE and BChE enzyme inhibitors is still ongoing. In this investigation analogs of capsaicin, such as the pharmaceutical nonivamide, which is preferred in clinical settings for the topical treatment of pain, were explored in the search for appropriate inhibitors. Thus, to test their inhibitory effect on AChE and BChE, we synthesized a short series of derivatives derived from vanillylamide. Consequently, it was discovered that compounds 12, 34, and 35, which have Ki values in the sub-micromolar concentration range, are especially effective inhibitors. Compound 12 demonstrated dual mixed-type (competitive/uncompetitive) inhibitory activity for both enzymes; compound 34 showed selective mixed-type inhibitory activity for AChE, and compound 35 was found to have selective uncompetitive activity for AChE.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/-
dc.subject.ddc540-
dc.titleRevisiting capsaicin and nonivamide : their analogs exert strong inhibitory activity against cholinesteraseseng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleEuropean journal of medicinal chemistry reports-
local.bibliographicCitation.volume12-
local.bibliographicCitation.pagestart1-
local.bibliographicCitation.pageend13-
local.bibliographicCitation.publishernameElsevier-
local.bibliographicCitation.publisherplaceAmsterdam-
local.bibliographicCitation.doi10.1016/j.ejmcr.2024.100200-
local.openaccesstrue-
dc.identifier.ppn1906297010-
cbs.publication.displayform2024-
local.bibliographicCitation.year2024-
cbs.sru.importDate2024-10-21T06:45:19Z-
local.bibliographicCitationEnthalten in European journal of medicinal chemistry reports - Amsterdam : Elsevier, 2021-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
1-s2.0-S2772417424000724-main.pdf3.22 MBAdobe PDFThumbnail
View/Open